Laura Ibanez

Additional Titles & Roles

---

• Assistant Professor of Neurology

Education & Training

---

• Ph.D.: University of Barcelona, 2015
• M.S.: University of Barcelona, 2008
• B.S.: University of Barcelona, 2007
• B.A.: University of Barcelona, 2007

Major Awards

---

• ESO WSO 2020 Young Investigator Award, 2020
• CZI Neurodegeneration Community Projects, 2019
• Spanish HIV Fundation (FIPSE) travel award, 2013
• PhD Fellowship from the Catalan Goverenment – FIDGR, 2010

View clinician profile

Research Interests

---

My research interests are focused on using genetics to improve the management and well-being of people that suffer from neurodegenerative diseases. Currently there is a great potential in combining genomics and bioinformatics, especially machine learning. Predictive models can easily be used in clinical settings to improve the management and quality of life of patients. My research is focused on the application novel bioinformatics tools to unique longitudinal datasets to create a predictive models for neurodegenerative diseases. My current research aims to create predictive models for Alzheimer Disease and Parkinson’s disease using cell free RNA and cell free DNA present in the plasma of afected individuals.

Visit lab website

Recent Publications

---

• Exploring MAPT-containing H1 and H2 haplotypes in Parkinson’s disease across diverse populations

  the Latin American Research Consortium on the Genetics of Parkinson’s Disease (LARGE-PD) & the Global Parkinson’s Genetics Program (GP2), Dec 2026, In: npj Parkinson’s Disease. 12, 1, 187.

• GWAS meta-analysis of cerebrospinal fluid Alzheimer’s biomarkers reveals loci regulating lipids, brain volume and autophagy

  Timsina, J., Jiang, C., McCartney, D. L., Tao, F., Dalmasso, M. C., Najar, J., Anastasi, F., Ohlei, O., Puerta Fuentes, R., Yang, C., Bradley, J., Western, D., Ali, M., Wang, C., Yang, C., Wu, Y., Liu, M., Budde, J., Williams, J. & Mahoney, R. & 135 others, Castillo Morales, A., Hohman, T. J., Dumitrescu, L., Wang, T. C., Tesi, N., Kern, S., Waern, M., Skoog, I., van Harten, A., Pijnenburg, Y. A. L., van der Flier, W. M., Sánchez-Juan, P., Rodriguez-Rodriguez, E., Kleineidam, L., Peters, O., Schneider, A., Küçükali, F., Bellenguez, C., Grenier-Boley, B., Heikkinen, S., de Rojas, I., Rujescu, D., Scherbaum, N., Hausner, L., Düzel, E., Grimmer, T., Wiltfang, J., Vandenberghe, R., Engelborghs, S., Heilmann-Heimbach, S., Schmid, M., Tegos, T., Scarmeas, N., Dols-Icardo, O., Moreno, F., Pérez-Tur, J., Bullido, M. J., Sánchez-Valle, R., Álvarez, V., García-González, P., Mir, P., Real, L. M., Piñol-Ripoll, G., García-Alberca, J. M., Seelaar, H., Ramakers, I., Papma, J., Hulsman, M., Laske, C., Teipel, S., Priller, J., Perneczky, R., Buerger, K., Nöthen, M. M., Lewczuk, P., Kornhuber, J., Hampel, H., Giegling, I., Goldhardt, O., Diehl-Schmid, J., Andrade, V., Heneka, M. M. T., Frölich, L., Vogelgsang, J., Graff, C., Thonberg, H., Ullgren, A., Papenberg, G., Deleuze, J. F., Dufouil, C., Wagner, M., Jessen, F., Holstege, H., van Duijn, C., Lebouvier, T., Hannon, O., Leinonen, V., Soininen, H., Herukka, S. K., Giedraitis, V., Löwenmark, M., Kilander, L., Genius, P., Rodríguez, B., Luckett, E. S., Navarro, A., Cano, A., Marquié, M., Blennow, K., Zetterberg, H., Lleo, A., Boada, M., Ruiz, A., Lee, V. M. Y., Van Deerlin, V. M., Deming, Y., Johnson, S. C., Engelman, C. D., Pastor, P., Alvarez, I., Peskind, E. R., Heslegrave, A. J., Saykin, A. J., Nho, K., Schindler, S. E., Morris, J. C., Holtzman, D. M., McDade, E., Renton, A. E., Goate, A., Ibanez, L., Riemenschneider, M., Albert, M. S., Laws, S. M., Porter, T., O’Brien, E. K., Shaw, L. M., Tijms, B. M., Ingelsson, M., Visser, P. J., Hiltunen, M., Sleegers, K., Ritchie, C. W., Sims, R., Belloy, M., Lambert, J. C., Vilor-Tejedor, N., Fernández, M. V., Li, Q. S., Nagle, M. W., Marioni, R. E., Ramirez, A., Bertram, L., van der Lee, S. J. & Cruchaga, C., Dec 2026, In: Nature communications. 17, 1, 7385.

• Genome-wide association study of copy number variations in Parkinson’s disease

  the Global Parkinson Genetics Program (GP2) & Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (COURAGE-PD) consortium, Dec 2026, In: npj Parkinson’s Disease. 12, 1, 160.

• Genetic modifiers of APOE-ε4-associated cognitive decline

  The Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer’s Disease Genetics Consortium (ADGC) & The Alzheimer’s Disease Sequencing Project (ADSP), Dec 2026, In: Nature communications. 17, 1, 2982.

• Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson’s disease

  Beric, A., Sahin, S., Sanchez, S., Yang, Z., Kumar, R., Alfradique-Dunham, I., Sanford, J., Western, D., Phillips, B., Budde, J. P., Perrin, R., Kotzbauer, P. T., Perlmutter, J. S., Norris, S., Cruchaga, C. & Ibanez, L., Oct 2026, In: Brain. 149, 10, p. 3509-3523 15 p.

See more publications

See NCBI publications

Funded Research Projects

---

View NIH Research